New Product Development
The analgesics market is on track to achieve a revenue of USD 91.62 billion in 2024. The market share of analgesics is increasing continuously in the drugs and medication sector, which has the ability to translate into a CAGR of 4.60% during the forecast period. This promising growth of the industry is slated to culminate …
Continue reading “Analgesics Market to Grow at a CAGR of 4.6% Through 2034”
The injectable drug delivery market is a critical segment within the pharmaceutical and healthcare industries, primarily focusing on the administration of medications through injections. This method offers precise dosing and rapid onset of action, making it essential for treatments ranging from chronic diseases to acute medical conditions. Injectable drug delivery systems have evolved significantly over …
Continue reading “Injectable Drug Delivery Market to Reach USD 113.87 Billion by 2034”
The global canine arthritis treatment market stands at a valuation of USD 2.50 billion in 2024. Global demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.20% and attain a market valuation of USD 3.77 billion by 2034. The canine arthritis treatment market has been gaining significant traction in recent …
Continue reading “Canine Arthritis Treatment Market Valued at USD 2.5 Billion in 2024”
The global peripheral vascular stent market, valued at USD 4.26 billion in 2024 to reach USD 8.87 billion by 2034, at a CAGR of 7.60%. The self-expanding segment is the most lucrative segment with a growth rate of 52.40% over the forecast period 2025 to 2035. The peripheral vascular stent industry in China is predicted …
Continue reading “Peripheral Vascular Stent Market Expected to Reach USD 8.87 Billion by 2034”
The amniotic membrane market is estimated to stand at USD 1,510.6 million in 2024. The market is forecasted to exceed a valuation of USD 2,279.5 million by 2034, recording a CAGR of 4.2%. Amniotic membrane demand is primarily driven by the therapeutic potential it offers in various medical applications, such as wound healing, ophthalmology, and …
Continue reading “Amniotic Membrane Market to Surpass USD 2.27 Billion by 2034”
The enzyme replacement therapy market has gained significant momentum over recent years, driven by rising awareness of rare diseases and growing access to modern healthcare services. Enzyme replacement therapy (ERT) is a medical treatment designed to replace deficient or absent enzymes in patients suffering from specific metabolic disorders. These therapies are commonly used in conditions …
Continue reading “Enzyme Replacement Therapy Market Poised for Healthy CAGR of 6.6%”
The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are inactive substances used alongside active pharmaceutical ingredients (APIs) to ensure stability, bioavailability, and effective delivery of the drug. As the demand for biologics such as monoclonal antibodies, …
Continue reading “Biologic Excipient Market Forecasted to Expand from USD 1.5 Billion in 2024”
The global behavioral health market is estimated at USD 127 billion in 2024 and is anticipated to generate revenues of USD 175.7 billion by 2034. The industry is forecast to rise at a CAGR of 3% in the forecast period. The behavioural health market encompasses a broad range of services and treatments designed to address …
Continue reading “Behavioral Health Market Projected to Grow at 3% CAGR Through 2034”
The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare cardiovascular diseases. Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the arteries that supply the lungs, which can lead to heart failure if left …
The Muscle Stimulation Devices Market is valued at USD 781.9 million USA dollars in 2025. The market to grow through CAGR 3.9% over the forecast years and is expected to reach USD 1,146.6 million by 2035. The muscle stimulation devices market is witnessing consistent growth due to the increasing demand for non-invasive therapies that promote …
Continue reading “Muscle Stimulation Devices Market Set for Steady Growth Through 2035”
